Laboratory

Photo

Coronavirus infection response

SARS-CoV-2 IgG II antibody test launched in CE Mark countries

Clinical diagnostics company Beckman Coulter launched its Access SARS-CoV-2 IgG II assay in countries accepting the CE Mark. The new Access SARS-CoV-2 IgG II assay quantitatively measures a patient’s level of antibodies in response to a previous SARS-CoV-2 infection. The ability to establish a quantitative baseline to evaluate an individual’s immune response to the SARS-CoV-2 virus allows…

Photo

Frontal part of the nose

Covid-19 Antigen Test: CE Mark for easier sample collection

Siemens Healthineers announced CE mark has been achieved to use anterior nose swab sampling for the Clinitest Rapid Covid-19 Antigen test. This sampling method can be less cumbersome and time consuming for both the provider and the patient. The test is a point-of-care cassette test that does not require laboratory instruments or specialized lab personnel to administer, and it delivers results in…

Photo

Glioma detection

Breakthrough liquid biopsy test to detect mutations in brain tumours

Researchers at Massachusetts General Hospital (MGH) in Boston have developed a novel blood test using an enhanced form of liquid biopsy capable of detecting the most common types of genetic mutations that occur in glioma brain tumors. The test is easy to use, inexpensive, produces results rapidly, and can be performed in most clinical laboratories. The researchers believe that the blood test has…

Photo

Coping with Covid-19

How to work in the lab (while staying at home)

Inspired by remotely controlled surgical robots, professor and Vici laureate Jaime Gómez Rivas turned the corona crisis into an opportunity. He started to transform his lab into a remotely controlled experimental facility. And with success: the first paper based on entirely remote measurements is about to be published. ‘As soon as the lockdown began in March, I sat down and had a chat with my…

Photo

In-vitro diagnostics

Join Mindray at 2020 AACC Virtual Event

The 2020 AACC Annual Scientific Meeting & Clinical Lab Expo is just around the corner, and this year, we are going virtual! At Mindray, we are dedicated to empowering TRUST through technology, innovation, and commitment to the advances of science in the in-vitro diagnostics field. Join our virtual community now, and explore Mindray’s reliable solutions trusted by laboratories worldwide. You…

Photo

Point-of-care testing

epoc NXS Host Mobile Computer for POCT received CE, FDA clearance

Siemens Healthineers announced it has received CE Mark and 510(k) clearance from the U.S. Food and Drug Administration for the epoc NXS Host mobile computer. The epoc Blood Analysis System with the new epoc NXS Host offers an easy-to-use, hand-held device with intuitive software application to further advance point-of-care testing. The epoc NXS Host incorporates caregiver suggestions that enhance…

Photo

High-sensitivity troponin I assay

Speeding up diagnosis of myocardial infarction

The new generation troponin I assay unveiled by Beckman Coulter is helping improve heart attack diagnosis. Delivering high sensitivity, and rapid result turnaround times, every element of the Access hsTnI assay has been redeveloped and updated, including the antibodies and the paramagnetic particles used. As specialists in developing and manufacturing products that simplify and automate complex…

Photo

Congress

Healthcare: Why Focus On Digitalization?

Health industry digitalization is one of the highest priorities in the healthcare sector these times. In perspective, it improves current living standards with quicker and easier access to help. The Healthcare Automation and Digitalization Congress business program will cover digital trends in the healthcare industry. The Congress will take place in Zurich, Switzerland on the 22nd - 23rd of…

Photo

Clinical lab equipment

Why do Mass Spectrometers need to be Medical Devices?

Clinical biochemistry laboratories face many daily challenges, including managing high sample workloads, managing clinician requests for novel tests, and generating and reporting out results in a timely fashion. Irrespective of the methodology employed, high quality and reproducible results are imperative since patient diagnosis and treatment plans are based largely on lab results. For this…

Photo

New gargle test

Mass spectrometry to improve Covid testing

A UK biotech laboratory has used mass spectrometry in a new approach to coronavirus testing. MAP Sciences developed a gargle test, which collects samples from the back of the throat, and avoids the unpleasant sensation of the current PCR (polymerase chain reaction) swab tests. From there, the sample is tested for coronavirus using mass spectrometry (MS) with high levels of accuracy.

Photo

MEDICA session

PCR tests excel during Covid-19 pandemic

In early 1990, at Analytica, in Munich, a young US-American researcher Kary B Mullis received the award for biochemical analytics for his 1983 invention: the polymerase chain reaction (PCR) – a success topped in 1993 by the Nobel Prize for chemistry. Mullis’ work revolutionised DNA copying, a process which, before PCR, had taken weeks. Whilst initially PCR was used to create digital…

Photo

Cardiac troponin I concentration measured at POC

Triage aided by a quick sensitive test

Large proportions of patients can be safely triaged either to rule out discharge or rule in lifesaving management – if following the European Society of Cardiology (ESC) Guidelines Class I recommendation of two serial measurements of hs-cTnI on admission and after one hour, if there are assay specific cut off values for the 0/1 algorithms. The Pathfast hs-cTNI assay is an approved system to…

Photo

In countries accepting CE Mark

Beckman Coulter launches SARS-CoV-2 IgM antibody test

Beckman Coulter announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR. Beckman Coulter’s IgM assay is part of a full suite of testing solutions the company is developing to…

Photo

False positive results

Accuracy of rapid covid test may be lower than previously suggested

The accuracy of a rapid finger-prick antibody test for SARS-CoV-2, the virus responsible for covid-19 infection, may be considerably lower than previously suggested, finds a study published by The BMJ. The results suggest that if 10% of people given the test had previously been infected, around 1 in 5 positive test results would be incorrect (false positive results). These conclusions contrast…

Photo

Quality aspects

Lab automation – economic aspects and Covid-19

The academic teaching Karlsruhe Hospital, at the University of Freiburg, is the largest hospital providing tertiary care in the Middle Upper Rhine Valley. Every year, 63,000 in-patients and 180,000 out-patients are treated in the 1,500-bed facility with 50 departments and 30 out-patient clinics. Inevitably, a hospital of this size has a central lab. We spoke with Dr Horst Mayer, managing senior…

Photo

Product of the Month

Needlestick Injuries are history

Injuries due to contaminated puncture devices are still the most frequent cause of accidents in hospitals. This is a significant source of danger for many employees in the healthcare industry. At this moment in time, there are already more than 20 bloodborne pathogens that we know of. The most dangerous are HBV, HCV and HIV. Recent studies show that it is up to ten times more likely for more…

Photo

Mass spectrometry-based metabolomics

A new technique to understand metabolic pathways

Mass spectrometry-based metabolomics has emerged as a powerful tool to help study chemical ecology. Recent advances in the technique make it possible to study microbial interactions from complex communities. Laia Castaño-Espriu outlined the role and benefits of MS in this context in her presentation ‘Analysis of microbial ecology by mass spectrometry-based metabolomics techniques’, at the…

Photo

Rapid diagnostics

The clinical potential of POCT

In 2019, the Central Laboratory of the Institute for Clinical Chemistry and Pathobiochemistry at the Klinikum rechts der Isar of the Technical University Munich, headed by Professor Peter B Luppa, organised the 4th of the internationally renowned Munich Point-of-Care Testing Symposiums. Dr Andreas Bietenbeck is senior physician at the Institute which for many years has been focusing on…

Photo

Revealing innovation potential of new antibiotics

Using proteomic profiling to accelerate drug development

The fight against bacterial infections, especially those caused by resistant pathogens, is in full swing with the search for new antibiotic agents. The aim is to identify substances that attack the pathogens in a truly novel way. The team at the Center for Systems-Based Antibiotic Research (Cesar) at Ruhr-Universität Bochum (RUB) has described in two publications how assess if a new antibiotic…

Photo

Challenges in acute care

POCT: Understanding sources of error

In an emergency, point-of-care-testing can provide results in minutes. However, sources of error must be understood to ensure result accuracy and confident diagnosis (particularly important during the current pandemic). Medical teams frequently use POCT devices to assess acutely ill patients; a hospital’s diagnostic laboratory is responsible for the analysers, plus training non-laboratory…

Photo

POCT for the head

New device detects traumatic brain injury 'on the spot'

A method for detecting traumatic brain injury at the point of care has been developed by scientists at the University of Birmingham. Using chemical biomarkers released by the brain immediately after a head injury occurs, researchers are able to pinpoint when patients need urgent medical attention. This saves time in delivering vital treatment and avoids patients undergoing unnecessary tests where…

826 show more articles
Subscribe to Newsletter